Skip to Main Content

Advertisement

Skip Nav Destination

Newsroom

Inquiries

Rory Williams
Director of Communications and Marketing
212-327-8603
[email protected]

Ben Short
Senior Manager of Science Communications and Marketing
212-327-7053
[email protected]
 

Follow us on X/Twitter: JCB | JEM | JGP | RUP

Embargoed media alerts and PIO Tip Sheets

Sign up for a weekly preview of articles to be published in Journal of Cell Biology(JCB), Journal of Experimental Medicine (JEM), and Journal of General Physiology (JGP) by contacting Rory Williams. Media alerts are for journalists only. Rockefeller University Press (RUP) also posts PIO Tip Sheets in EurekAlert every Tuesday to notify authors’ institutions of articles that have been accepted for publication in RUP journals.

Latest Press Releases

Researchers identify new way to inhibit immune cells that drive allergic asthma.
Researchers at the Keck School of Medicine, University of Southern California, have discovered that a protein called Piezo1 prevents a type of immune cell in the lung from becoming hyperactivated by allergens. The study, to be published March 26 in the Journal of Experimental Medicine (JEM), suggests that switching on Piezo1 could represent a new therapeutic approach to reducing lung inflammation and treating allergic asthma. Read more…
Mar 26, 2024 10:00 AM

Newly identified yeast could prevent fungal infections by outcompeting rivals, study suggests.
Researchers at the Weizmann Institute of Science in Israel have identified a yeast that could be used to prevent invasive candidiasis, a major cause of death in hospitalized and immunocompromised patients. The study, to be published March 18 in the Journal of Experimental Medicine (JEM), shows that the novel yeast lives harmlessly in the intestines of mice and humans and can displace the yeast responsible for candidiasis, Candida albicans. Read more…
Mar 18, 2024 10:00 AM

Recent media coverage

3/24/24 — Researchers identify new way to inhibit immune cells that drive allergic asthma — Journal of Experimental Medicine
US News & World Report, GENNews, USC, MSNHealth Day, MedicalXpress, Drugs.com, UPIANI News, Latestly
RUP Press Release - Article

3/18/24 — Newly identified yeast could prevent fungal infections by outcompeting rivals, study suggests — Journal of Experimental Medicine
Jerusalem Post, Weizmann InstituteBioworld, GENNews, MSN, Phys.org, ANI News, Latestly, Gate2Biotech
RUP Press Release - Article

9/29/23 — Study identifies new pathway to suppressing autoimmunity — Journal of Experimental Medicine
Fierce Biotech, GEN News, The Medical News, Medical News Today, MedicalXpress, Infosalus, La Razon, ScienceNewsNet, BioNews Central, Mirage, ScienMag, Bioengineer
RUP Press Release - Article

8/24/23 — Mutations in blood stem cells can exacerbate colon cancer — Journal of Experimental Medicine
GEN News, GenomeWeb, The Medical News, eCancer, MedicalXpress, Medindia, ANI News, Germanic News, Punta Cana Hits, ScienceNewsNet, Mirage, Devdiscourse, The Print, New Kerala
RUP Press Release - Article

3/17/23 – New gene-editing technique reverses vision loss in mice – Journal of Experimental Medicine
BBC Focus, Optometry Today, Ophthalmology Times, Healthline, Health Day, Interesting Engineering, Forbes, GEN News, New Atlas, Technology Networks, Genomeweb, Laboratory Equipment, sina.com, news.cn, and more.
RUP Press Release - Article

Embargo policy

Rockefeller University Press (RUP) makes embargoed material available to eligible journalists and public information officers for research articles appearing in its three journals: Journal of Cell Biology (JCB), Journal of Experimental Medicine (JEM), and Journal of General Physiology (JGP). Eligible individuals must agree to follow the terms of the RUP embargo policy:

  • Stories or reports on research articles may not be published or placed in the public domain until 10:00 a.m. US Eastern Time on the day of publication. Precise embargo dates and times are clearly marked on all advance material.
  • Public information officers (PIOs) may not distribute embargoed materials in the public domain before the embargo date. However, embargoed materials may be distributed to the media by public information officers. Such releases must be clearly identified as embargoed and must include the embargo date and time. PIOs are responsible for taking all necessary steps to ensure that the embargo is honored by all third parties.
  • All material from RUP journals can be reused without permission for noncommercial purposes, but must be attributed to the appropriate journal and shared expressly under the same restrictions. See our Creative Commons policy for more information.
Close Modal

or Create an Account

Close Modal
Close Modal